Congenital chylothorax treated with octreotide

Indian Journal of Pediatrics

Volumn 72, Issue 10, 2005, Pages 885-888

  Sahin, Yasin ^a,b   Aydin, Derya ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Congenital chylothorax; Neonate; Octreotide

Indexed keywords

FRESH FROZEN PLASMA; HUMAN ALBUMIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ARTICLE; CASE REPORT; CHYLE; CHYLOTHORAX; CONSERVATIVE TREATMENT; DRUG SAFETY; FEMALE; HUMAN; LYMPH FLOW; LYMPHATIC DRAINAGE; NEWBORN; PATENT DUCTUS ARTERIOSUS; PLEURA CAVITY; PLEURA EFFUSION; POSITIVE END EXPIRATORY PRESSURE; THORAX DRAINAGE;

APGAR SCORE; CHYLOTHORAX; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; OCTREOTIDE; PLEURAL EFFUSION; RESPIRATION, ARTIFICIAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 27844592301     PISSN: 00195456     EISSN: 00195456     Source Type: Journal    
DOI: 10.1007/BF02731124     Document Type: Article

References (28)

1. Smeltzer DM, Stickler GB, Fleming RE. Primary lymphatic dysplasia in children: Chylothorax, chylous ascites, and generalised lymphatic dysplasia. Eur J Pediatr 1986; 45: 286-292.
2. Levine C. Primary disorders of the lymphatic vessels-a unified concept. J Pediatr Surg 1989; 24: 233-240.
3. Hilliard RI, McKendry JB, Phillips MJ. Congenital abnormalities of the lymphatic system: a new clinical classification. Pediatr 1990; 86: 988-994.
4. Adiotomre PN, Burns JE, McIntosh N. Hydrops foetalis and chylothorax associated with superior caval vein obstruction and resolution following balloon dilatation. Acta Pediatr 1994; 83: 983-985.
5. Easa D, Balaraman V, Ash K, Thompson B, Boychuk R. Congenital Chylothorax and mediastinal neuroblastoma. Pediatrie Surg 1991; 26: 96-98.
6. Hesseling PB, Hoffman H. Chylothorax: a review of the literature and report of 3 cases. S Afr Med 1981; 60: 675-678.
7. Ho NK, Leong NK, Lim SB. Chylothorax in Down's syndrome associated with hydrops fetalis. J Singapore Pediatr Soc 1989; 31: 90-92.
8. Harvey JG, Houlsby W, Sherman K, Gough MH. Congenital Chylothorax: report of unique case associated with 'H-type tracheooesophageal fistula. Br J Surg 1979; 66: 485-487.
9. Azizkhan RG, Canfield J, Alford BA, Rodgers BM. Pleuroperitoneal shunts in the management of neonatal chylothorax. J Pediatric Surg 1983; 18: 842-850.
10. Anderson EA, Hertel J, Pedersen SA et al. Congenital chylothorax: Management by ligature of the thoracic duct. Scand J Thorac Cardiovasc Surg 1984; 18: 193-194.
11. Al-Tawil K, Ahmed G, Al-Hathal M, Al-Jarallah Y, Campbell N. Congenital chylothorax. Am J Perinatol 2000; 17: 121-126.
12. Wolff AB, Silen ML, Kokoska ER, Rodgers BM. Treatment of refractory chylothorax with externalised pleuroperitoneal shunts in children. Ann Thorac Surg 1999; 68: 1053-1057.
13. Buettiker V, Hug MI, Burger R, Baenziger O. Somatostatin: A new therapeutic option for the treatment of chylothorax. Intens Care Med 2001; 27: 1083-1086.
14. Rosti L, Bini RM, Chessa M, Butera G, Drago M, Carminati M. The effectiveness of octreotide in the treatment of postoperative chylothorax. Eur J Pediatr 2002; 161: 149-150.
15. Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr 2001; 139: 157-159.
16. Pratap U, Slavik Z, Ofoe VD, Franklin R. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg 2001; 72: 1740-1742.
17. Lam JC, Aters S, Tobias JD. Initial experience with Octreotide in the pediatric population. Am J Ther 2001; 8: 409-415.
18. Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Pediatr Child Health 2004; 40: 585-588.
19. Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le Coultre C. Etiology and management of pediatric chylothorax. J Pediatrics 2000; 136: 653-658.
20. Chernick V, Reed MH. Pneumothorax and chylothorax in the neonatal period. J Pediatrics 1970; 76: 624-632.
21. Dubin PJ, King IN, Gallagher PG. Congenital Chylothorax. Curr Opin Pediatr 2000; 12: 505-509.
22. Mulvihill S, Pappas TN, Passaro E Jr, Debas HT. The use of somatostatin and its analogs in the treatment of surgical disorders. Surgery 1986; 100: 467-475.
23. Siafakas C, Fox VL, Nurko S. Use of octreotide for the treatment of severe gastrointestinal bleeding in children. J Pediatr Gastroenterol Nutr 1998; 26: 356-359.
24. Tauber MT, Harris AG, Rochiccioli P. Clinical use of the long acting somatostatin analogue octreotide in pediatrics. Eur J Pediatr 1994; 153: 304-310.
25. Lamberts SWJ, van der Lely AJ, de Herder WW, Hofland LJ. Drug therapy: Octreotide. N Engl J Med 1996; 334: 246-254.
26. Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycaemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr 1993; 123: 644-650.
27. th (edn). New York; Pergamon Press, 1996; 1512-1513.
28. Nakabayashi H, Sagara H, Usukura N, Yoshimitsu K, Imamura T, Seta T, Yanase E, Kawato M, Hiraiwa Y, Sakato S, Takeda R. Effect of somatostatin on the flow rate and triglyceride levels of thoracic duct lymph in normal and vagotomised dogs. Diabetes 1981; 30: 440-445.